NCT00766142 2025-08-29
COCHISE
Institut Bergonié
Phase 2 Terminated
Clinical Trials
9 trialsNCT04826432 2024-02-08
PASIREOCHIP
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Terminated
NCT03352414 2021-08-18
ILEUS
University of California, San Diego
Phase 2 Terminated
NCT03150628 2019-04-17
CISCA
UMC Utrecht
Phase 2 Terminated
NCT01540344 2018-09-05
COMBATAC
University of Regensburg
Phase 2 Terminated
NCT01681368 2017-05-30
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01116791 2015-12-02
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
University Hospital, Gasthuisberg
Phase 2 Terminated
NCT00516841 2012-08-23
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Facet Biotech
Phase 2 Terminated
NCT00445549 2012-06-26
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated